Monthly Archives: March 2013

Home/2013/March

First report of a GIST patient responding to a BRAF inhibitor

First report of a GIST patient responding to a BRAF inhibitor. Dr. Gerald Falchook and colleagues at MD Anderson Cancer Center provided the first report of a GIST patient responding to a BRAF inhibitor. The BRAF gene is frequently mutated in melanoma and BRAF inhibitors provide one of the most important therapies available for melanoma patients

By |2019-09-20T12:57:43-04:00March 14th, 2013|News, Research|

LRG Urges Governor Christie to Restore Cancer Funding

The LRG is continually involved in advocacy efforts to increase government spending on cancer research. We have joined forces with other cancer agencies to once again urge Governor Chris Christie and the New Jersey Legislature to restore the $1 million budget appropriation

By |2019-09-20T12:58:11-04:00March 13th, 2013|Advocacy, News|
Go to Top